Myrtelle Inc. funding
Myrtelle Inc., a biotechnology company based in New York, NY (founded 2021), filed a Form D with the SEC on July 2, 2026 and reported $16.7M raised of a $30M offering. It filed 2 new offerings in this period, totaling $47.2M.
Amount raised$16.7M
Offering size$30M
Filed with the SECJuly 2, 2026
First saleJune 22, 2026
IndustryBiotechnology
SecuritiesDebt, Options or warrants, Security to be acquired on exercise
LocationNew York, NY
Founded2021
Entity typeCorporation
Investors so far3
Minimum investment$25K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 2
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| July 2, 2026 | $16.7M | $30M | Debt, Options or warrants, Security to be acquired on exercise |
| December 23, 2025 | $30.5M | $55.2M | Equity, Other |
Other health care rounds in New York
Precision Neuroscience Corp$250M · Sep 28Other Health CareClick Therapeutics, Inc.$50M · Oct 1Other Health CareAmani Therapeutics, Inc.$35M · Oct 1Other Health CareAtmos Clinic, Inc.$6M · Oct 8Other Health CareCAD Therapeutics, Inc.$4M · Oct 2BiotechnologyPreciseDx, Inc.$3.7M · Oct 7Other Health CareHypercell Technologies Inc.$3M · Oct 14BiotechnologyAmorSui Inc.$2.7M · Sep 23Other Health Care